Fear of Cancer Recurrence in Peritoneal Malignancy Patients- Version 1
Research type
Research Study
Full title
Fear of Cancer Recurrence in Peritoneal Malignancy Patients following Complete Cytoreductive Surgery (CCRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
IRAS ID
295431
Contact name
Rayan/RT Taher
Contact email
Sponsor organisation
Hampshire Hospitals NHS Foundation Trust
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Major surgery and giving heated chemotherapy during surgery is the gold standard treatment for rare cancers that develop in or spread to the thin layer of tissue that lines the abdomen, called the peritoneum. These cancers are called Peritoneal Malignancies. The surgery that these patients receive is called cytoreductive surgery (CRS) followed with a heated chemotherapy.
Previous studies show that "Fear of Cancer Recurrence" is cancer patients' number one unmet need. Previous research in colorectal cancer patients found that high levels of fear of cancer recurrence is associated with worse quality of life. Patients with higher fear of cancer recurrence are more likely to use healthcare services to ease their anxiety increasing the cost to healthcare or they avoid seeking help from health services out of fear. There is no research on the levels of fear of cancer recurrence in peritoneal malignancy patients. This study aims to explore these levels in peritoneal malignancy patients and see if there is a relationship between fear of cancer recurrence and quality of life in these patients. This study will also explore what characteristics (age, gender, disease grade...) are associated with higher fear of cancer recurrence levels in these patients.
Peritoneal malignancy patients who have had surgery at Basingstoke Hospital in the last five years will be invited to take part in this study. They will be sent questionnaires that measure their levels of fear of cancer recurrence and quality of life via mail or email depending on their preference. Participants who choose to participate will be in the study for 2-3 weeks (from date of invitation till date of questionnaire completion). The questionnaires are estimated to take 30-45 minutes to complete.
REC name
East Midlands - Leicester South Research Ethics Committee
REC reference
21/EM/0168
Date of REC Opinion
11 Aug 2021
REC opinion
Further Information Favourable Opinion